TY - JOUR
T1 - Longitudinal tracking of left atrial diameter over the adult life course
T2 - Clinical correlates in the community
AU - McManus, David D.
AU - Xanthakis, Vanessa
AU - Sullivan, Lisa M.
AU - Zachariah, Justin
AU - Aragam, Jayashri
AU - Larson, Martin G.
AU - Benjamin, Emelia J.
AU - Vasan, Ramachandran S.
PY - 2010/2
Y1 - 2010/2
N2 - BACKGROUND-: Increased left atrial diameter (LAD) is associated with elevated risk of atrial fibrillation (AF) and cardiovascular disease. Information is limited regarding the short-or long-term correlates of LAD. METHODS AND RESULTS-: We evaluated clinical correlates of LAD for a 16-year period in 4403 Framingham Study participants (mean age, 45 years; 52% women; median observations/participant=3) using multilevel modeling. We related age, sex, body mass index (BMI), systolic and diastolic blood pressure (BP), diabetes, and antihypertensive treatment to LAD. Sex-specific growth curves for LAD were estimated for individuals with low, intermediate, and high risk factor burden. We also related risk factors to changes in LAD during a 4-year period in 3365 participants. Age, male sex (3.83 mm compared to women), greater BMI, higher systolic BP (0.24 mm per 10 mm Hg increment), and antihypertensive treatment (0.54 mm) were associated positively with LAD (P<0.001). Men had a greater increase in LAD with BMI than women (2.02 versus 1.77 mm in women, per 5-unit increment), and individuals receiving antihypertensive treatment experienced a greater increase in LAD with age (0.95 versus 0.63 mm per 10-year age increment) when compared with those not receiving antihypertensive treatment. Overall, greater risk factor burden was positively associated with LAD. These risk factors were also associated positively with 4-year change in LAD (P<0.001). CONCLUSIONS-: Our longitudinal study of a large community-based sample identified higher BP and greater BMI as key modifiable correlates of LAD, suggesting that maintaining optimal levels of these risk factors through the life course may prevent atrial remodeling and AF.
AB - BACKGROUND-: Increased left atrial diameter (LAD) is associated with elevated risk of atrial fibrillation (AF) and cardiovascular disease. Information is limited regarding the short-or long-term correlates of LAD. METHODS AND RESULTS-: We evaluated clinical correlates of LAD for a 16-year period in 4403 Framingham Study participants (mean age, 45 years; 52% women; median observations/participant=3) using multilevel modeling. We related age, sex, body mass index (BMI), systolic and diastolic blood pressure (BP), diabetes, and antihypertensive treatment to LAD. Sex-specific growth curves for LAD were estimated for individuals with low, intermediate, and high risk factor burden. We also related risk factors to changes in LAD during a 4-year period in 3365 participants. Age, male sex (3.83 mm compared to women), greater BMI, higher systolic BP (0.24 mm per 10 mm Hg increment), and antihypertensive treatment (0.54 mm) were associated positively with LAD (P<0.001). Men had a greater increase in LAD with BMI than women (2.02 versus 1.77 mm in women, per 5-unit increment), and individuals receiving antihypertensive treatment experienced a greater increase in LAD with age (0.95 versus 0.63 mm per 10-year age increment) when compared with those not receiving antihypertensive treatment. Overall, greater risk factor burden was positively associated with LAD. These risk factors were also associated positively with 4-year change in LAD (P<0.001). CONCLUSIONS-: Our longitudinal study of a large community-based sample identified higher BP and greater BMI as key modifiable correlates of LAD, suggesting that maintaining optimal levels of these risk factors through the life course may prevent atrial remodeling and AF.
KW - Atrial enlargement
KW - Epidemiology
KW - Left atrial diameter
KW - Multilevel modeling
KW - Serial measurements
UR - https://www.scopus.com/pages/publications/76649095364
UR - https://www.scopus.com/pages/publications/76649095364#tab=citedBy
U2 - 10.1161/CIRCULATIONAHA.109.885806
DO - 10.1161/CIRCULATIONAHA.109.885806
M3 - Article
C2 - 20100973
AN - SCOPUS:76649095364
SN - 0009-7322
VL - 121
SP - 667
EP - 674
JO - Circulation
JF - Circulation
IS - 5
ER -